Gayatri Saraf

2 papers in the library · 31 citations · publishing 2023-2025

Papers

Sort Most recent Most cited

Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.

European Neuropsychopharmacology November 7, 2025 Mikkel Højlund, Helin Y. Kafali, Begüm Kırmızı et al. 12 citations

Serotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a continuously evolving evidence base. We searched Pubmed/Scopus/clinical trial registries up to 08july2025 for double-blind randomized controlled trials (RCTs) testing MDMA or serotonergic psychedelics in patients with mental disorders. Primary outcomes were change in...

DOI: 10.1016/j.euroneuro.2025.09.011 Psychedelic therapy MDMA Therapy Psychedelic medicine Entheogenic therapy +12

New Pharmacologic Approaches to the Treatment of Bipolar Depression.

Drugs July 1, 2023 Kamyar Keramatian, Trisha Chakrabarty, Anais DuBow et al. 19 citations

Depression is the most commonly experienced mood state over the life span in individuals with bipolar disorder (BD) and is the primary driver of functional impairment and suicidality in BD. Despite this, there are few effective treatments for BD depression, with only a handful of atypical anti-psychotics and inconsistent evidence for traditional mood stabilizing agents. There have been few...

DOI: 10.1007/s40265-023-01872-x Full text Mental-health Psychiatric-treatment Bipolar-disorder Depression-therapy +1